Advanced renal cell carcinoma: mixed results in relapse therapy

Advanced renal cell carcinoma: mixed results in relapse therapy

0 Comments

Barcelona – There are now a whole range of therapeutic options for advanced renal cell carcinoma, which primarily include anti-angiogenic drugs such as tyrosine kinase inhibitors (TKI) and immune checkpoint inhibitors. Optimization of the… [weiter